Category: CLSI
CLSI
CLSI NBS07-Ed1
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E
standard by Clinical and Laboratory Standards Institute, 03/01/2017
CLSI M28-A2
Procedures for the Recovery and Identification of Parasites From the Intestinal Tract; Approved Guideline, M28A2E
standard by Clinical and Laboratory Standards Institute, 06/30/2005
CLSI M43-A
Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AE
standard by Clinical and Laboratory Standards Institute, 10/01/2011
CLSI I/LA18-A2
Specifications for Immunological Testing for Infectious Diseases; Approved Guideline-Second Edition, ILA18A2E
standard by Clinical and Laboratory Standards Institute, 09/20/2001
CLSI QMS05-A2
Quality Management System: Qualifying, Selecting, and Evaluating a Referral Laboratory; Approved Guideline – Second Edition, QMS05A2E
standard by Clinical and Laboratory Standards Institute, 09/01/2012
CLSI NBS08
Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E
standard by Clinical and Laboratory Standards Institute, 10/28/2019
CLSI C40-A2
Analytical Procedures for the Determination of Lead in Blood and Urine; Approved Guideline, C40A2E
standard by Clinical and Laboratory Standards Institute, 10/01/2013
CLSI GP33-A
Accuracy in Patient and Sample Identification; Approved Guideline, GP33A
standard by Clinical and Laboratory Standards Institute, 03/01/2010
CLSI GP31-A
Laboratory Instrument Implementation, Verification, and Maintenance, Approved Guideline, GP31AE
standard by Clinical and Laboratory Standards Institute, 04/01/2009
CLSI GP17-A3 (R2018)
Clinical Laboratory Safety; Approved Guideline – Third Edition, GP17A3E
standard by Clinical and Laboratory Standards Institute, 06/01/2012